Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,487 | 157 | 98.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $80.00 | 2 | 1.4% |
| Education | $11.71 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $2,088 | 37 | $0 (2024) |
| Esperion Therapeutics, Inc. | $724.89 | 33 | $0 (2024) |
| GlaxoSmithKline, LLC. | $714.67 | 12 | $0 (2024) |
| Novo Nordisk Inc | $491.50 | 22 | $0 (2024) |
| ABBVIE INC. | $409.53 | 12 | $0 (2024) |
| Insulet Corporation | $229.76 | 6 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $200.36 | 6 | $0 (2023) |
| Lilly USA, LLC | $107.07 | 7 | $0 (2023) |
| Amgen Inc. | $100.00 | 1 | $0 (2019) |
| Biohaven Pharmaceutical Holding Company Ltd. | $81.81 | 4 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,846 | 47 | AstraZeneca Pharmaceuticals LP ($772.38) |
| 2023 | $1,941 | 47 | AstraZeneca Pharmaceuticals LP ($795.10) |
| 2022 | $1,576 | 61 | AstraZeneca Pharmaceuticals LP ($520.51) |
| 2020 | $60.00 | 1 | GENZYME CORPORATION ($60.00) |
| 2019 | $119.78 | 2 | Amgen Inc. ($100.00) |
| 2018 | $36.05 | 2 | SANOFI-AVENTIS U.S. LLC ($20.00) |
All Payment Transactions
160 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $10.48 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/26/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $7.01 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $105.21 | General |
| Category: Respiratory | ||||||
| 11/19/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: RESPIRATORY | ||||||
| 11/07/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $10.46 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 10/30/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 10/24/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $5.37 | General |
| 10/11/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $12.95 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 10/04/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: Respiratory | ||||||
| 09/30/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $10.56 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 09/20/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $11.31 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 09/19/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/17/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $104.72 | General |
| Category: Insulin Pump | ||||||
| 09/13/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: Respiratory | ||||||
| 09/12/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $124.99 | General |
| 09/11/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 08/23/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.81 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/23/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $9.04 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 08/21/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: RESPIRATORY | ||||||
| 08/15/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: RESPIRATORY | ||||||
| 08/13/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $12.22 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 08/01/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: Respiratory | ||||||
| 07/15/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $11.31 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 07/02/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: Respiratory | ||||||
| 07/01/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 318 | 412 | $40,507 | $22,786 |
| 2022 | 8 | 283 | 431 | $40,973 | $26,897 |
| 2021 | 13 | 452 | 519 | $71,541 | $30,811 |
| 2020 | 12 | 448 | 549 | $68,733 | $27,256 |
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 94 | 152 | $20,324 | $10,940 | 53.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 47 | 47 | $7,953 | $5,872 | 73.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 64 | 70 | $6,253 | $2,342 | 37.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 13 | 13 | $2,914 | $1,421 | 48.8% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 11 | 11 | $990.00 | $833.91 | 84.2% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 37 | 57 | $836.14 | $542.64 | 64.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 14 | 14 | $560.00 | $413.14 | 73.8% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2023 | 15 | 24 | $461.54 | $343.20 | 74.4% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 23 | 24 | $216.00 | $77.66 | 36.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 86 | 198 | $25,097 | $17,102 | 68.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 34 | 34 | $5,447 | $4,392 | 80.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 67 | 74 | $7,195 | $3,713 | 51.6% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2022 | 17 | 32 | $482.75 | $480.91 | 99.6% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 16 | 16 | $1,042 | $357.38 | 34.3% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 23 | 35 | $407.59 | $335.06 | 82.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 11 | 11 | $322.64 | $315.53 | 97.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 29 | 31 | $980.00 | $201.50 | 20.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 123 | 168 | $24,175 | $13,329 | 55.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 86 | 86 | $34,400 | $11,305 | 32.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 31 | 31 | $3,175 | $1,596 | 50.3% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2021 | 19 | 19 | $1,425 | $1,196 | 83.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 12 | 12 | $2,820 | $934.78 | 33.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 35 | 35 | $1,400 | $568.35 | 40.6% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 43 | 54 | $1,188 | $524.34 | 44.1% |
| 90756 | Vaccine for influenza derived from cell cultures for injection into muscle, quadrivalent, antibiotic free, 0.5ml dosage | Office | 2021 | 14 | 14 | $560.00 | $395.84 | 70.7% |
About Dr. Maritza Baez, MD
Dr. Maritza Baez, MD is a Family Medicine healthcare provider based in Buffalo, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/14/2007. The National Provider Identifier (NPI) number assigned to this provider is 1285849877.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Maritza Baez, MD has received a total of $5,578 in payments from pharmaceutical and medical device companies, with $1,846 received in 2024. These payments were reported across 160 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($5,487).
As a Medicare-enrolled provider, Baez has provided services to 1,501 Medicare beneficiaries, totaling 1,911 services with total Medicare billing of $107,750. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Buffalo, NY
- Active Since 05/14/2007
- Last Updated 08/02/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1285849877
Products in Payments
- FARXIGA (Drug) $621.48
- BREZTRI (Drug) $617.26
- AREXVY (Drug) $488.83
- AIRSUPRA (Drug) $457.65
- VRAYLAR (Drug) $409.53
- NEXLETOL (Drug) $372.73
- NEXLIZET (Drug) $352.16
- LOKELMA (Drug) $246.01
- Omnipod (Device) $229.76
- Kerendia (Drug) $200.36
- FASENRA (Biological) $124.99
- Rybelsus (Drug) $116.63
- TRELEGY ELLIPTA (Drug) $100.85
- Aimovig (Biological) $100.00
- SOLIQUA 100/33 (Biological) $89.96
- NURTEC ODT (Drug) $81.81
- TRULICITY (Drug) $74.86
- ZIO XT Patch (Device) $67.92
- ELIQUIS (Drug) $47.87
- Ozempic (Drug) $47.52
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Buffalo
Martin Mahoney, Md, MD
Family Medicine — Payments: $631,123
Michael Zionts, Md, MD
Family Medicine — Payments: $21,271
Dr. Kelly Kinnan, M.d, M.D
Family Medicine — Payments: $18,189
Dr. Raul Vazquez, M.d, M.D
Family Medicine — Payments: $14,950
Dr. Ryan Bowe, Md, MD
Family Medicine — Payments: $11,387
Chester Fox, Md, MD
Family Medicine — Payments: $11,324